Mark Kowalski
2019 - ProNAi Therapeutics
In 2019, Mark Kowalski earned a total compensation of $897.5K as Chief Medical Officer at ProNAi Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $164,388 |
|---|---|
| Option Awards | $297,713 |
| Salary | $432,600 |
| Other | $2,800 |
| Total | $897,501 |
Kowalski received $432.6K in salary, accounting for 48% of the total pay in 2019.
Kowalski also received $164.4K in non-equity incentive plan, $297.7K in option awards and $2.8K in other compensation.
Rankings
In 2019, Mark Kowalski's compensation ranked 9,768th out of 13,971 executives tracked by ExecPay. In other words, Kowalski earned more than 30.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,768 out of 13,971 | 30th |
Division Manufacturing | 3,939 out of 5,701 | 31st |
Major group Chemicals And Allied Products | 1,499 out of 2,200 | 32nd |
Industry group Drugs | 1,282 out of 1,886 | 32nd |
Industry Pharmaceutical Preparations | 950 out of 1,398 | 32nd |
Source: SEC filing on April 24, 2020.
Kowalski's colleagues
We found two more compensation records of executives who worked with Mark Kowalski at ProNAi Therapeutics in 2019.